Markets

Tech Mahindra Unveils AI-Powered Drug Safety Solution With NVIDIA

March 19, 2025 — 11:14 am EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Tech Mahindra (TECHM) Wednesday announced that it has introduced an autonomous pharmacovigilance solution powered by NVIDIA AI software to enhance drug safety management.

This innovative system leverages artificial intelligence and automation to improve accuracy, speed, and efficiency in monitoring adverse drug reactions while addressing industry challenges like manual delays and data overload.

Built on Tech Mahindra's TENO framework and NVIDIA's advanced AI technology, the solution automates pharmacovigilance workflows, streamlining case intake, data transformation, quality control, and compliance management. It incorporates NVIDIA AI Enterprise software, including NeMo, NIM microservices, and AI Blueprints, to ensure seamless processing.

AI-driven agents autonomously classify, prioritize, and verify pharmacovigilance emails, reducing human error. The system accelerates turnaround times by 40 percent, improves data accuracy by 30 percent, and lowers operational costs by 25 percent, shifting pharmacovigilance from reactive monitoring to proactive risk management.

TECHM closed Wednesday's trading at INR 1,396.35, down INR 34.80 or 2.43 percent on the Bombay Stock Exchange.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Markets

Latest Articles
Data is currently not available